Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
Seong Hoon Jeong, Nam Young Lee, Se Hyun Kim, In Won Chung, Tak Youn, Ung Gu Kang, Yong Min Ahn, Han Young You, Yong Sik Kim
Psychiatry Investig. 2018;15(6):628-637.   Published online 2018 Jun 21     DOI: https://doi.org/10.30773/pi.2018.01.18.1
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu
International Journal of Molecular Sciences.2022; 23(13): 7092.     CrossRef
Effect of liraglutide 3.0mg treatment on weight reduction in obese antipsychotic-treated patients
Seung Eun Lee, Nam Young Lee, Se Hyun Kim, Kyoung-Ah Kim, Yong Sik Kim
Psychiatry Research.2021; 299: 113830.     CrossRef
Effects of Short-term Mobile Application Use on Weight Reduction for Patients with Type 2 Diabetes
Seung Eun Lee, Su-Kyung Park, Ye-Seul Park, Kyoung-Ah Kim, Han Seok Choi, Sang Woo Oh
Journal of Obesity & Metabolic Syndrome.2021; 30(4): 345.     CrossRef
Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia
Ted Boozalis, Sridevi Devaraj, Olaoluwa O. Okusaga
Psychiatric Quarterly.2019; 90(1): 101.     CrossRef
Assessment of Long Term Metabolic Effects of Atypical Antipsychotics in Schizophrenia Patients
Nicolae-Marius Cason, Petru Aurel Babeş, Enikő Béres, Katalin Babeş
Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2019; 26(3): 267.     CrossRef